Dare Bioscience, Inc. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Dare Bioscience, Inc. stock issued during period, shares, new issues for the quarter ending 2022-12-31 was 0.00 shares.
- Dare Bioscience, Inc. stock issued during period, shares, new issues for the quarter ending 2022-09-30 was -49.00K shares, a 100.27% decline year-over-year.
- Dare Bioscience, Inc. stock issued during period, shares, new issues for the quarter ending 2021-12-31 was -18.90M shares.
- Dare Bioscience, Inc. stock issued during period, shares, new issues for the quarter ending 2021-09-30 was 18.30M shares.
- Dare Bioscience, Inc. stock issued during period, shares, new issues for fiscal 2022 was 751.00K shares, a 89.42% decline from fiscal 2021.
- Dare Bioscience, Inc. stock issued during period, shares, new issues for fiscal 2021 was 7.10M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 751.00K shares 10-K · filed 2023-03-30 |
| 2022-09-30 | -49.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | |
| 2021-12-31 | -18.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 7.10M shares 10-K · filed 2023-03-30 |
| 2021-09-30 | 18.30M shares 10-Q · filed 2021-11-10 | |
| 2019-09-30 | 0.00 shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 0.00 shares 10-Q · filed 2019-08-14 | |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-14 | |
| 2018-09-30 | 0.00 shares 10-Q · filed 2019-11-12 | |
| 2018-06-30 | 0.00 shares 10-Q · filed 2019-08-14 | |
| 2018-03-31 | 375.00K shares 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |